NO20026122L - Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater - Google Patents
Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivaterInfo
- Publication number
- NO20026122L NO20026122L NO20026122A NO20026122A NO20026122L NO 20026122 L NO20026122 L NO 20026122L NO 20026122 A NO20026122 A NO 20026122A NO 20026122 A NO20026122 A NO 20026122A NO 20026122 L NO20026122 L NO 20026122L
- Authority
- NO
- Norway
- Prior art keywords
- depression
- piperazine derivatives
- therapeutic preparation
- anxiety neurosis
- neurosis
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000192856 | 2000-06-27 | ||
PCT/JP2001/005524 WO2002000259A1 (fr) | 2000-06-27 | 2001-06-27 | Agent therapeutique contre l'anxiete nevrotique ou la depression et derive de piperazine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20026122D0 NO20026122D0 (no) | 2002-12-19 |
NO20026122L true NO20026122L (no) | 2003-02-25 |
Family
ID=18691931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20026122A NO20026122L (no) | 2000-06-27 | 2002-12-19 | Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater |
Country Status (22)
Country | Link |
---|---|
US (1) | US6949552B2 (ko) |
EP (1) | EP1295608A4 (ko) |
JP (1) | JP5002881B2 (ko) |
KR (1) | KR20030013470A (ko) |
CN (1) | CN1438897A (ko) |
AU (2) | AU2001266342B2 (ko) |
BG (1) | BG107371A (ko) |
BR (1) | BR0111976A (ko) |
CA (1) | CA2413506A1 (ko) |
CZ (1) | CZ20024165A3 (ko) |
EA (2) | EA005737B1 (ko) |
EE (1) | EE200200717A (ko) |
HR (1) | HRP20030056A2 (ko) |
HU (1) | HUP0301719A2 (ko) |
IL (1) | IL153706A0 (ko) |
MX (1) | MXPA02012707A (ko) |
NO (1) | NO20026122L (ko) |
NZ (1) | NZ523800A (ko) |
PL (1) | PL360286A1 (ko) |
SK (1) | SK18322002A3 (ko) |
WO (1) | WO2002000259A1 (ko) |
ZA (1) | ZA200210386B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE200200717A (et) | 2000-06-27 | 2004-08-16 | Taisho Pharmaceutical Co., Ltd. | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
WO2003013571A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
JPWO2003053927A1 (ja) * | 2001-12-21 | 2005-04-28 | 大正製薬株式会社 | ピペラジン誘導体 |
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
US7968548B2 (en) * | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
US7419980B2 (en) * | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
US7491723B2 (en) | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
EP1867641A4 (en) * | 2005-04-04 | 2010-01-13 | Takeda Pharmaceutical | A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS |
US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
US20080108574A1 (en) * | 2006-09-27 | 2008-05-08 | Braincells, Inc. | Melanocortin receptor mediated modulation of neurogenesis |
EP2072050A1 (en) * | 2007-12-21 | 2009-06-24 | Santhera Pharmaceuticals (Schweiz) AG | Compounds with anti-emetic effect |
WO2011026959A1 (de) | 2009-09-07 | 2011-03-10 | Vifor (International) Ag | Neue ethandiamin-hepcidin-antagonisten |
US8609672B2 (en) | 2010-08-27 | 2013-12-17 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
CA2825098C (en) | 2011-01-27 | 2020-03-10 | Universite De Montreal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1317053A (fr) * | 1961-03-17 | 1963-02-01 | Soc Ind Fab Antibiotiques Sifa | Nouveaux dérivés de la pipérazine, et procédé de préparation |
CA918659A (en) * | 1969-07-31 | 1973-01-09 | Yoshitomi Pharmaceutical Industries | 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines |
FR2601364B1 (fr) * | 1986-07-09 | 1988-10-21 | Adir | Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
GB9021453D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
JPH0641071A (ja) * | 1991-09-06 | 1994-02-15 | Taisho Pharmaceut Co Ltd | インドール酢酸エステル誘導体 |
GB9200293D0 (en) | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
SE9700620D0 (sv) | 1997-02-21 | 1997-02-21 | Wapharm Ab | Cykliska peptider med selektivitet för MSH-receptor subtyper |
AU742425B2 (en) * | 1998-06-11 | 2002-01-03 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
EE200200717A (et) | 2000-06-27 | 2004-08-16 | Taisho Pharmaceutical Co., Ltd. | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
-
2001
- 2001-06-27 EE EEP200200717A patent/EE200200717A/xx unknown
- 2001-06-27 HU HU0301719A patent/HUP0301719A2/hu unknown
- 2001-06-27 PL PL36028601A patent/PL360286A1/xx not_active Application Discontinuation
- 2001-06-27 NZ NZ523800A patent/NZ523800A/en unknown
- 2001-06-27 SK SK1832-2002A patent/SK18322002A3/sk unknown
- 2001-06-27 US US10/311,429 patent/US6949552B2/en not_active Expired - Fee Related
- 2001-06-27 EA EA200300071A patent/EA005737B1/ru not_active IP Right Cessation
- 2001-06-27 KR KR1020027017682A patent/KR20030013470A/ko not_active Application Discontinuation
- 2001-06-27 BR BR0111976-1A patent/BR0111976A/pt not_active IP Right Cessation
- 2001-06-27 CA CA002413506A patent/CA2413506A1/en not_active Abandoned
- 2001-06-27 IL IL15370601A patent/IL153706A0/xx unknown
- 2001-06-27 MX MXPA02012707A patent/MXPA02012707A/es unknown
- 2001-06-27 AU AU2001266342A patent/AU2001266342B2/en not_active Ceased
- 2001-06-27 EA EA200500087A patent/EA200500087A1/ru unknown
- 2001-06-27 EP EP01943844A patent/EP1295608A4/en not_active Withdrawn
- 2001-06-27 AU AU6634201A patent/AU6634201A/xx not_active Withdrawn
- 2001-06-27 CZ CZ20024165A patent/CZ20024165A3/cs unknown
- 2001-06-27 WO PCT/JP2001/005524 patent/WO2002000259A1/ja not_active Application Discontinuation
- 2001-06-27 JP JP2002505040A patent/JP5002881B2/ja not_active Expired - Fee Related
- 2001-06-27 CN CN01811767A patent/CN1438897A/zh active Pending
-
2002
- 2002-12-11 BG BG107371A patent/BG107371A/bg unknown
- 2002-12-19 NO NO20026122A patent/NO20026122L/no not_active Application Discontinuation
- 2002-12-20 ZA ZA200210386A patent/ZA200210386B/en unknown
-
2003
- 2003-01-27 HR HR20030056A patent/HRP20030056A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BG107371A (bg) | 2003-08-29 |
US20030186992A1 (en) | 2003-10-02 |
NZ523800A (en) | 2005-02-25 |
MXPA02012707A (es) | 2003-04-25 |
EP1295608A4 (en) | 2004-03-31 |
WO2002000259A1 (fr) | 2002-01-03 |
SK18322002A3 (sk) | 2003-09-11 |
HRP20030056A2 (en) | 2005-02-28 |
IL153706A0 (en) | 2003-07-06 |
EA200500087A1 (ru) | 2005-06-30 |
ZA200210386B (en) | 2004-02-10 |
EE200200717A (et) | 2004-08-16 |
CA2413506A1 (en) | 2002-12-20 |
EP1295608A1 (en) | 2003-03-26 |
EA200300071A1 (ru) | 2003-06-26 |
EA005737B1 (ru) | 2005-06-30 |
CZ20024165A3 (cs) | 2004-03-17 |
KR20030013470A (ko) | 2003-02-14 |
JP5002881B2 (ja) | 2012-08-15 |
AU2001266342B2 (en) | 2005-01-27 |
AU6634201A (en) | 2002-01-08 |
US6949552B2 (en) | 2005-09-27 |
PL360286A1 (en) | 2004-09-06 |
NO20026122D0 (no) | 2002-12-19 |
CN1438897A (zh) | 2003-08-27 |
HUP0301719A2 (hu) | 2003-09-29 |
BR0111976A (pt) | 2003-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20026122L (no) | Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater | |
EE200200656A (et) | Ravis kasutatavad tropaani derivaadid | |
DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
NO20030596D0 (no) | Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse | |
NO20021400D0 (no) | Terapeutiske konazolinderivater | |
DK1419150T3 (da) | 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse | |
NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
DK1353919T3 (da) | Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme | |
DK1161434T3 (da) | Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse | |
NO20025158D0 (no) | Lipidpreparat og anvendelse derav | |
NO20015897L (no) | Indolylpiperidinderivater som antihistaminiske og antiallergiske midler | |
DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO20034413D0 (no) | Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
DK1525193T3 (da) | Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse | |
IS6723A (is) | 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar | |
DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf | |
NO20030156D0 (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
NO20030547L (no) | Azabicykliske derivater og deres terapeutiske anvendelse | |
NO20033120D0 (no) | 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav | |
NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
EE200300466A (et) | Püridoindolooni derivaatide kasutamine ravimite valmistamiseks | |
NO20001782D0 (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO20010630D0 (no) | Krummet trapp og trappetrinn for krummet trapp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |